Healthcare

HB 919 requires pharmacy benefit managers (PBMs) in Louisiana to reimburse pharmacies at least the National Average Drug Acquisition Cost (NADAC) plus the state's professional dispensing fee per prescription, with a minimum $12 per prescription. It prohibits PBMs from owning or contracting with pharmacies (including subsidiaries) and mandates annual transparency reports detailing foreign subsidiaries and financial arrangements with drug manufacturers. PBMs violating these rules face fines up to $100,000 per violation for executives, with unlimited liability for large PBMs ($500M+ revenue). The law applies retroactively to prescriptions filled between January 1, 2025, and December 1, 2025, and becomes fully effective for new requirements in 2027. These provisions directly affect pharmacies, pharmacists, and PBMs operating in Louisiana.

HB 469 establishes a $100 annual optional "pharmacy education support fee" for pharmacists and pharmacies renewing licenses or permits in Louisiana. Pharmacists and pharmacies can choose whether to pay the fee or select a specific public university pharmacy school (like Xavier University) to receive it, with the option to opt out entirely. Funds collected must supplement, not replace, existing university funding for pharmacy education programs. The Louisiana Board of Pharmacy will distribute payments to chosen schools by April 1 each year, ensuring the money directly supports pharmacy education initiatives at public universities.